The UF Health Pediatric Blood and Marrow Transplantation (BMT) and Cell Therapy Program offers novel treatments to patients with high-risk malignancies, immunological disorders, and bone marrow failure syndromes that are not available anywhere else in this region. Our team is known for our highly patient-centric, holistic approach, leading to outstanding treatment outcomes.
Our program was the first in Florida to receive accreditation from the Foundation for Accreditation of Hematopoietic Cell Transplantation (FACT).
The Pediatric Blood and Marrow Transplantation and Cell Therapy Program, in collaboration with the UF Health Cancer Center, uses a multidisciplinary patient care approach that optimizes patient outcomes and satisfaction. We are affiliated with Children’s Oncology Group, NAPAAC, Pediatric Transplantation and Cellular Therapy, and initiated the Florida pediatric bone marrow transplant and cell therapy consortium.
Our program has successfully performed stem cell transplantation to treat a broad variety of malignant and benign hematologic disorders, including but not limited to:
- Acute leukemia, chronic leukemia and myelodysplastic syndromes
- Severe aplastic anemia
- Inherited bone marrow failure syndromes, including Fanconi anemia, Dyskeratosis Congenita, Schwachmann Diamond, Diamond Blackfan Anemia
- Hemoglobinopathies, including thalassemia and sickle cell disease
- Hemophagocytic lymphohistiocytosis
- Primary immunodeficiencies: Severe Combined Immunodeficiency (SCID), Common Variable Immune Deficiency
- Inherited metabolic disorders
- Brain Tumors
- Refractory Solid Tumors
We are advancing care through Car-T Cell Therapy, institutional clinical trials, and collaborative trials. We provide cellular graft manipulation techniques to overcome limitations associated with stem cell transplantation. We have dedicated researchers working to advance the field of cellular therapy and provide precision medicine in the future.